INVENTIVA SA reports a Return on Equity (ROE) of 2,290.08%.

What is IVA's dividend yield?

INVENTIVA SA offers a dividend yield of 0.00%.

What is IVA's Deepscope Quality Score?

Deepscope rates IVA's overall financial quality at 62 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy IVA?

Deepscope's AI Timing Score for IVA is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does IVA belong to?

INVENTIVA SA is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

หุ้น IVA (NASDAQ) | INVENTIVA SA – วิเคราะห์โดย Deepscope

Stock Check ข้อมูลอัปเดตรายวัน ที่เวลา 09.30 น.
(Price: 2026-06-05 | FS: 2026-03-31)

IVA

INVENTIVA SA

US:NASDAQ STOCK Healthcare >> Biotechnology News 88

USD 4.03

-0.20 (-4.73%) Day Change

Watchlist Portfolio Compare Chart

-1.10

D/E

2,290.1%

ROE

-267.2%

ROA

0.00%

Div Yield

INVENTIVA SA
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 4.03 Price -0.20 (-4.73%) Day Change	NEWS SCORE: 88

IVA มีคุณภาพโดยรวมพอใช้ ( คะแนนปัจจัยพื้นฐาน = 62) และ จังหวะเข้าซื้อ ...(ล็อกอินเพื่อดู)...

Loading chart...

62 QUALITY

Signal: NEUTRAL

Signal Description: Company financial health is OK

Reason: อัตราผลตอบแทนสินทรัพย์ (ROA) ค่อนข้างต่ำ
อัตราผลตอบแทนสินทรัพย์ (ROA) ค่อนข้างต่ำเมื่อเทียบกับอัตราผลตอบแทนผู้ถือหุ้น(ROE)
อัตราการเติบโตของอัตราผลตอบแทนสินทรัพย์(ROA) ปัจจุบันต่ำกว่าเกณฑ์
อัตรากำไรสุทธิ ค่อนข้างต่ำ
อัตรากำไรสุทธิในอดีต ค่อนข้างต่ำ

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

ถ้าดูอย่างละเอียดจะพบว่า ปัจจัยทางคุณภาพ ยังไม่ดีนัก สุขภาพทางการเงิน ไม่ดี และ ประสิทธิภาพการทำกำไร พอใช้ , ...

ปัจจัยทางคุณภาพ

51%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	88
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	4.03
PBV / Sector	-30.44 / 4.63
Earning Per Share	-3.03

PE / Sector	N/A / 17.43
PEG or PE/Growth / Sector	N/A / 0.53
Average 1M Daily Value	2.37 M GREAT
Average 1W Daily Value	5.78 M GREAT

ปัจจัยทางเทคนิค

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

สุขภาพทางการเงิน

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ประสิทธิภาพการทำกำไร

64%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-6,058.35 / 449.48
NPM Average (%) / Sector	-3,345.27 / -1,506.49
NPM Change Average (%) / Sector	129.37 / 4,940.99 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-267.17 / 30.58
ROA Average (%) / Sector	-152.85 / -347.17
ROA Change Average (%) / Sector	80.15 / 5,125.52 GREAT
ROE (%) / Sector	2,290.08 / -3.58
ROE Average (%) / Sector	771.95 / 40.65 GREAT
ROE Change Average (%) / Sector	58.74 / 2,109.80 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

ผลตอบแทนต่อผู้ถือหุ้น

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 4.17

รายละเอียดการจดทะเบียน

Analyze Date	2026-06-06 09:08:47
Symbol	IVA
Name	INVENTIVA SA
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	208.95 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	883.85 / 8,857.28

ข่าว, ประมาณการ, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 50 rue de Dijon, Daix, France, 21121

Phone: 33 3 80 44 75 00

Website: https://inventivapharma.com

Employees: 69

Sector: Healthcare >> Biotechnology

Description: Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. It develops Lanifibranor, a novel peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. The company also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. Inventiva S.A. was incorporated in 2011 and is headquartered in Daix, France.